Saqib Naseer, MD, partner at Manchester, Conn.-based New England Cardiology Associates, who has been caring for patients at Manchester Memorial Hospital, claims he and three other area practices have ...

In May, the University of Vermont Medical Center sought approval to build a $129 million outpatient surgery center in South Burlington, Vt., but construction on the planned facility has now been ...

Vancouver, Wash.-based PeaceHealth is planning to acquire four medical clinics from Renton, Wash.-based Providence, according to an Oct. 3 report from The Columbian. The acquisitions will be finalized ...

HSHS St. Elizabeth’s Hospital is seeking approval for a $50 million expansion at its O'Fallon, Ill.-based medical campus, according to an Oct. 4 report from the Belleville News-Democrat.

Medical office building space in Jacksonville, Fla., is rapidly shrinking in comparison to tenant needs, according to a Sept. 30 report from the Jacksonville Business Journal.

Discover how the Johns Hopkins Wilmer Eye Institute is using a $10 million donation to establish an artificial intelligence center.

A federal judge in Florida has dismissed a whistleblower lawsuit accusing a medical practice of inflating Medicare reimbursements, citing constitutional concerns over the False Claims Act's qui tam ...

Here are five payer moves in September for ASCs to know, as reported by Becker's: 1. On Sept. 1, UnitedHealthcare rolled out its list of eligible procedures under its national prior authorization gold ...

The FDA has approved the Cologuard Plus test, a next-generation, multitarget stool DNA test approved for patients at an average risk for colorectal cancer. The FDA's approval was based on findings ...

A physician who ran an addiction treatment practice in Merrillville, Ind., has been sentenced to one year and one day in federal prison after pleading guilty to healthcare fraud.

Here are three proactive strategies in avoiding malpractice suits, according to the report: ...

Participants in the clinical trial, which took place in 2008, used the drops or a placebo for four months. The short-term trial suggested that the drops gave some patients clearer vision. But the ...